全文获取类型
收费全文 | 158495篇 |
免费 | 16333篇 |
国内免费 | 11006篇 |
专业分类
耳鼻咽喉 | 1185篇 |
儿科学 | 2131篇 |
妇产科学 | 1642篇 |
基础医学 | 15196篇 |
口腔科学 | 3164篇 |
临床医学 | 22304篇 |
内科学 | 19348篇 |
皮肤病学 | 1905篇 |
神经病学 | 5932篇 |
特种医学 | 5444篇 |
外国民族医学 | 64篇 |
外科学 | 12779篇 |
综合类 | 33750篇 |
现状与发展 | 44篇 |
一般理论 | 11篇 |
预防医学 | 14817篇 |
眼科学 | 4205篇 |
药学 | 18150篇 |
276篇 | |
中国医学 | 12856篇 |
肿瘤学 | 10631篇 |
出版年
2024年 | 696篇 |
2023年 | 2647篇 |
2022年 | 6613篇 |
2021年 | 8197篇 |
2020年 | 6674篇 |
2019年 | 5058篇 |
2018年 | 5063篇 |
2017年 | 5527篇 |
2016年 | 4711篇 |
2015年 | 7647篇 |
2014年 | 9262篇 |
2013年 | 9428篇 |
2012年 | 13761篇 |
2011年 | 14637篇 |
2010年 | 11048篇 |
2009年 | 9233篇 |
2008年 | 10132篇 |
2007年 | 9718篇 |
2006年 | 8652篇 |
2005年 | 7746篇 |
2004年 | 5117篇 |
2003年 | 4734篇 |
2002年 | 3878篇 |
2001年 | 2998篇 |
2000年 | 2593篇 |
1999年 | 2084篇 |
1998年 | 1219篇 |
1997年 | 1261篇 |
1996年 | 915篇 |
1995年 | 800篇 |
1994年 | 736篇 |
1993年 | 430篇 |
1992年 | 422篇 |
1991年 | 391篇 |
1990年 | 364篇 |
1989年 | 281篇 |
1988年 | 292篇 |
1987年 | 232篇 |
1986年 | 162篇 |
1985年 | 122篇 |
1984年 | 58篇 |
1983年 | 56篇 |
1982年 | 18篇 |
1981年 | 24篇 |
1980年 | 15篇 |
1979年 | 33篇 |
1975年 | 15篇 |
1974年 | 13篇 |
1973年 | 20篇 |
1969年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
1.
2.
目的 分析重庆市肺癌发病死亡和疾病负担归因于被动吸烟的情况,为开展肺癌防治提供建议。 方法 肺癌死亡个案数据来源于2019年重庆市肿瘤登记报告系统,被动吸烟率来自2013年重庆市慢性病及危险因素监测。计算人群归因危险度百分比(population attributable risk percent, PAR%)、被动吸烟导致的肺癌发病、死亡和疾病负担。采用Excel 2010与SPSS 25.0进行统计分析,率的比较采用χ2检验。 结果 2013年30岁及以上成年人被动吸烟率为52.37%。2019年重庆市30岁及以上人群肺癌发病率与标化发病率分别为118.44/10万与80.83/10万,死亡率与标化死亡率分别为96.51/10万、63.58/10万。肺癌发病率和死亡率归因于被动吸烟的PAR%分别为19.76和19.04,归因发病率与归因标化发病率分别为23.41/10万和16.34/10万,归因死亡率与归因标化死亡率分别为18.38/10万和12.40/10万。2019年重庆市30岁及以上肺癌早死所致寿命损失年率(years of life lost,YLL)、残疾所致寿命损失年率(years lived with disability,YLD)、调整伤残寿命损失年率(disability adjusted life year,DALY)分别为21.16‰、0.31‰、21.47‰,YLL率、YLD率、DALY率归因于被动吸烟的PAR%分别为21.16、19.76和20.49,归因YLL率为4.34‰,归因YLD率为0.06‰,归因DALY率为4.40‰。 结论 2019年重庆市30岁及以上人群肺癌发病率、死亡率、YLL率、DALY率高,被动吸烟率高,肺癌归因于被动吸烟的疾病负担重,应加强落实控烟工作。 相似文献
3.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献4.
Cardiac myxoma has varying clinical presentation, uncertain histogenesis and debatable immunohis- tochemical profile. Glandular epithelial differentiation is a rare phenomenon, but glandular elements are known to be present in cardiac myxoma as an intrinsic component of the tumor. We present a case of cardiac myxoma having focal glandular differentiation, with special reference to the morphologic features and immunohistochemical profiles. 相似文献
5.
戴慧芬教授治疗痛经的经验 总被引:2,自引:0,他引:2
严继林 《云南中医学院学报》1996,19(4):32-33
介绍了戴彗芬教授应用逍遥散、当归调经汤、温经汤、和经止痛汤,当归芍药散、当归四逆加吴萸、生姜汤、血府逐瘀汤治疗痛经的经验。 相似文献
6.
7.
目的 研究利福昔明对比环丙沙星治疗急性肠炎的有效性和安全性。 方法 采用随机对照方法 ,共治疗 5 1例急性肠炎。利福昔明治疗 2 5例 ,环丙沙星 2 6例 ,用药时间方法相同。观察治疗前后临床症状、大便性状、大便次数、便常规、血常规、尿常规及肝肾功能 ,以了解其疗效及不良反应情况。 结果 利福昔明组 (治疗组 )与环丙沙星组 (对照组 )相比 ,显效率分别为 92 .0 %和 80 .8% ,总有效率分别为 92 .0 %和 96 .2 % ,止泻时间治疗组 2 8.6 7± 15 .92h ,对照组 36 .12± 2 0 .70h ,均未见明显毒副作用。以上各项指标及两组在治疗过程中大便次数变化、大便常规复常率经统计学处理均无显著性差异 (P >0 0 5 )。 结论 利福昔明可用于治疗急性肠炎 ,与环丙沙星比较 ,疗效相仿 ,但耐受性好 ,口服不吸收 ,故值得推广 相似文献
8.
中西医结合治疗小儿急性肾小球肾炎临床观察 总被引:1,自引:0,他引:1
急性肾小球肾炎为临床常见病,多发于少年儿童,男性多见。西医除对症处理外,无特效药物,中药治疗本病可明显缩短病程。笔者自2003年1月至2006年1月用清热利湿解毒汤治疗急性肾小球肾炎60例取得确切疗效,现报道如下。 相似文献
9.
To study the pathological and histochemical characteristics of lesions in piglet livers infected with Taenia saginata asiatica (T. saginata asiatica) throughout the different stages, piglets were fed with eggs of T. saginata asiatica and raised in isolation in an animal center to establish the T. saginata asiatica infection model with normal piglets as control. The pathological changes in the piglet livers were observed after the infection
using liver sections stained with hematoxylin and eosin. Histochemical methods were used to check the changes in lipid, glycogen
and protein content in the liver. The data collected by image analysis were analyzed statistically with Statistical Package
for the Social Science. The results show that T. saginata asiatica-exposed piglets were indeed infected. Inflammatory reactions began on the fourth day and progressed rapidly. Kupffer cell
hyperplasia, hepatic hydropic degeneration and ballooning degeneration were found in the 10th–20th days after infection. Hepatic
central veins and hepatic sinusoids were dilated and congested. Spotty necrosis occurred in some local liver tissues. In the
40th–60th days, granulomatous reactions and mild hepatocirrhosis were the main lesions. In the 70th–80th days, hepatocirrhosis
and bile duct proliferation were observed in the liver. In the different stages, lipid drops were increased while glycogen
and protein levels were decreased to some degree. There was a significant difference in metabolism between the infected group
and the control group (P < 0.01). It is concluded that pigs are the favorable intermediate host of T. saginata asiatica and its infection can result in serious pathological and histochemical lesions in host organs.
Translated from Journal of Guiyang Medical College, 2006, 31(4): 296–300 [译自: 贵阳医学院学报] 相似文献
10.
Although many monoclonal antibodies have been made in human colon cancer, none of them are from the Chinese species. Recently, a colon cancer cell line CC-M2 established from a Chinese patient has been completely characterized and used as immunogen to produce monoclonal antibodies. Monoclonal antibodies were produced by standard hybridoma technique. The fusion rate was 95.8%. An isotype IgG1 of high proliferation named as Sam-2 was used in this study. The titers were measured around 10(4). Further studies on MoAb Sam-2 through indirect immunofluorescent and immunoperoxidase tests revealed its good specificity and sensitivity in colorectal cancer tissue. In CEA study, the result indicated that Sam-2 may react on a non-CEA related antigen. For further clinical application, the antigen was identified as a glycoprotein by chemical resistant test. In preliminary studies using sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting techniques, Sam-2 could recognize two closed antigens or a dimer antigen with molecular weight 25.2 and 27 Kd respectively. 相似文献